NasdaqHealth CarePharmaceutical PreparationsGAITHERSBURG, MD

Shuttle Pharmaceuticals Holdings, Inc. SHPH

Ask your AI

Estimated market cap $21.58M4.76M shares, shares as of Sep 21, 2026CIK 1757499

Insider trades, 12 mo

6 buys · 5 sells

$504.8K sold, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

0.8% of shares · 0 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q2 2026

What changed in Shuttle Pharmaceuticals Holdings, Inc.'s latest quarterly report, compared with the one before.

Filed Sep 24, 2026 · Quarter ended Jun 30, 2026

Compared with the 10-Q for the quarter ended Mar 31, 2026. Sections compared: risk factors and legal proceedings.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Shuttle Pharmaceuticals Holdings, Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

11 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Jul 14, 2026. Insiders have two business days to file.

Recent insider trades

HRT Financial LP 10% owner	Jul 14 Form 4 ↗	Sale	−$367.9K 82,116 sh @ $4.48	+8.6%
HRT Financial LP 10% owner	Jul 13 Form 4 ↗	Sale	−$4,824 1,033 sh @ $4.67	+52.3%
HRT Financial LP 10% owner	Jul 10 Form 4 ↗	Buy	+$2,273 731 sh @ $3.11	+55.2%
HRT Financial LP 10% owner	Jul 9 Form 4 ↗	Buy	+$27.9K 8,266 sh @ $3.38	+37.8%
HRT Financial LP 10% owner	Jul 8 Form 4 ↗	Sale	−$65.2K 18,531 sh @ $3.52	+25.7%

All SHPH insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

40,010 shares

4 funds report SHPH. Values checked against market prices.

Funds own 2.2% of shares (Q2 2026)

5 funds hold the stock.

Q3 2026: 0.8% · 5,560 of ~8,900 funds reported so far

Q2 20262.2%
Q3 2026 (so far)0.8%

Q3 2026. 3 new, 0 added to, 0 trimmed, 3 exited since Q2 2026.

Top 13F holders
#
1	Jane Street Group, LLC 13F ↗	19,445	$78.6K	New
2	Geode Capital Management, LLC 13F ↗	14,715	$59.4K	New
3	UBS Group AG 13F ↗	5,730	$23.1K	New
4	Kelleher Financial Advisors 13F ↗	120	$485	unchanged

Download CSV Every fund that holds SHPH, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Shuttle Pharmaceuticals Holdings, Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Shuttle Pharmaceuticals Holdings, Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report

Funds holding the stock by quarter

Q2 2026	5	—	104,210	$338.2K
Q3 2026	4	-1	40,010	$161.6K

Each point is a quarter-end, from Q2 2026 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (825693500). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2026) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits; none took place between these quarters. Values are in dollars as reported at the time and are not adjusted.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakesNone in 12 mo 8-K events9 in 90 days Patents1 patent granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive payNone on record Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials0 active IPO history9 registrations Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Shuttle Pharmaceuticals Holdings, Inc.
Address: 401 PROFESSIONAL DRIVE, SUITE 260, GAITHERSBURG, MD 20879
Phone: (240) 403-4212
Fiscal year ends: Dec 31
Filer category: emerging growth company
Incorporated in: DE
Listed as: SHPH (Nasdaq)
Former names: Shuttle Pharmaceuticals Holdings, Inc. (until 2026)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$4.53−$0.23 (−4.83%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $4.53 · High $5.59Nov 13, 2026

Aug 13, 2026Low $3.13 · High $5.59Nov 13, 2026

Nov 13, 2025Low $2.78 · High $25.00Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. The stock split 1-for-10 on Jun 11, 2026; earlier prices are shown divided by the split ratio. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.